- call +1-201-465-4211
- email sales@mrinsights.biz
Next generation sequencing (NGS) technology is used to sequence millions of small fragments of DNA simultaneously. The technology is similar to capillary electrophoresis where the bases of small fragments of DNA are sequentially identified from signals emitted, and each fragment is resynthesized from a DNA template strand.
Scope of the Report:
This report studies the Next Generation Sequencing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Next Generation Sequencing market by product type and applications/end industries.
The major difference is that NGS process is extended across millions of reactions in a massively parallel fashion, rather than restricted to a single or a few DNA fragments. This technology enables rapid sequencing of large stretches of DNA base pairs spanning entire genomes with highly sophisticated instruments capable of producing hundreds of gigabytes of data in a single sequencing run.
The global Next Generation Sequencing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Next Generation Sequencing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
DNAnexus
DNASTAR
Eagle Genomics
Edge Biosystems
GENEWIZ
Roche
Agilent Technologies
Biomatters
CLC Bio
GATC biotech
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology
EMC
Dnastar
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing
Market Segment by Applications, can be divided into
Whole-genome Sequencing
Exome Sequencing
Targeted Resequencing
De Novo Sequencing
RNA Sequencing
ChIP Sequencing
Methyl Sequencing
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Next Generation Sequencing Market Overview
1.1 Product Overview and Scope of Next Generation Sequencing
1.2 Classification of Next Generation Sequencing by Types
1.2.1 Global Next Generation Sequencing Revenue Comparison by Types (2017-2023)
1.2.2 Global Next Generation Sequencing Revenue Market Share by Types in 2017
1.2.3 Targeted Sequencing & Resequencing
1.2.4 Whole Genome Sequencing
1.2.5 Whole Exome Sequencing
1.3 Global Next Generation Sequencing Market by Application
1.3.1 Global Next Generation Sequencing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Whole-genome Sequencing
1.3.3 Exome Sequencing
1.3.4 Targeted Resequencing
1.3.5 De Novo Sequencing
1.3.6 RNA Sequencing
1.3.7 ChIP Sequencing
1.3.8 Methyl Sequencing
1.3.9 Others
1.4 Global Next Generation Sequencing Market by Regions
1.4.1 Global Next Generation Sequencing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Next Generation Sequencing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Next Generation Sequencing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Next Generation Sequencing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Next Generation Sequencing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Next Generation Sequencing Status and Prospect (2013-2023)
1.5 Global Market Size of Next Generation Sequencing (2013-2023)
2 Manufacturers Profiles
2.1 DNAnexus
2.1.1 Business Overview
2.1.2 Next Generation Sequencing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 DNAnexus Next Generation Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.2 DNASTAR
2.2.1 Business Overview
2.2.2 Next Generation Sequencing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 DNASTAR Next Generation Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eagle Genomics
2.3.1 Business Overview
2.3.2 Next Generation Sequencing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eagle Genomics Next Generation Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Edge Biosystems
2.4.1 Business Overview
2.4.2 Next Generation Sequencing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Edge Biosystems Next Generation Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.5 GENEWIZ
2.5.1 Business Overview
2.5.2 Next Generation Sequencing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GENEWIZ Next Generation Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Roche
2.6.1 Business Overview
2.6.2 Next Generation Sequencing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Next Generation Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Agilent Technologies
2.7.1 Business Overview
2.7.2 Next Generation Sequencing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Agilent Technologies Next Generation Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biomatters
2.8.1 Business Overview
2.8.2 Next Generation Sequencing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biomatters Next Generation Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.9 CLC Bio
2.9.1 Business Overview
2.9.2 Next Generation Sequencing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 CLC Bio Next Generation Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.10 GATC biotech
2.10.1 Business Overview
2.10.2 Next Generation Sequencing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GATC biotech Next Generation Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.11 Macrogen
2.11.1 Business Overview
2.11.2 Next Generation Sequencing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Macrogen Next Generation Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.12 BGI (Beijing Genomics Institute)
2.12.1 Business Overview
2.12.2 Next Generation Sequencing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 BGI (Beijing Genomics Institute) Next Generation Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.13 Illumina
2.13.1 Business Overview
2.13.2 Next Generation Sequencing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Illumina Next Generation Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.14 Life Technology
2.14.1 Business Overview
2.14.2 Next Generation Sequencing Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Life Technology Next Generation Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.15 EMC
2.15.1 Business Overview
2.15.2 Next Generation Sequencing Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 EMC Next Generation Sequencing Revenue, Gross Margin and Market Share (2016-2017)
2.16 Dnastar
2.16.1 Business Overview
2.16.2 Next Generation Sequencing Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Dnastar Next Generation Sequencing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Next Generation Sequencing Market Competition, by Players
3.1 Global Next Generation Sequencing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Next Generation Sequencing Players Market Share
3.2.2 Top 10 Next Generation Sequencing Players Market Share
3.3 Market Competition Trend
4 Global Next Generation Sequencing Market Size by Regions
4.1 Global Next Generation Sequencing Revenue and Market Share by Regions
4.2 North America Next Generation Sequencing Revenue and Growth Rate (2013-2018)
4.3 Europe Next Generation Sequencing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Next Generation Sequencing Revenue and Growth Rate (2013-2018)
4.5 South America Next Generation Sequencing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Next Generation Sequencing Revenue and Growth Rate (2013-2018)
5 North America Next Generation Sequencing Revenue by Countries
5.1 North America Next Generation Sequencing Revenue by Countries (2013-2018)
5.2 USA Next Generation Sequencing Revenue and Growth Rate (2013-2018)
5.3 Canada Next Generation Sequencing Revenue and Growth Rate (2013-2018)
5.4 Mexico Next Generation Sequencing Revenue and Growth Rate (2013-2018)
6 Europe Next Generation Sequencing Revenue by Countries
6.1 Europe Next Generation Sequencing Revenue by Countries (2013-2018)
6.2 Germany Next Generation Sequencing Revenue and Growth Rate (2013-2018)
6.3 UK Next Generation Sequencing Revenue and Growth Rate (2013-2018)
6.4 France Next Generation Sequencing Revenue and Growth Rate (2013-2018)
6.5 Russia Next Generation Sequencing Revenue and Growth Rate (2013-2018)
6.6 Italy Next Generation Sequencing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Next Generation Sequencing Revenue by Countries
7.1 Asia-Pacific Next Generation Sequencing Revenue by Countries (2013-2018)
7.2 China Next Generation Sequencing Revenue and Growth Rate (2013-2018)
7.3 Japan Next Generation Sequencing Revenue and Growth Rate (2013-2018)
7.4 Korea Next Generation Sequencing Revenue and Growth Rate (2013-2018)
7.5 India Next Generation Sequencing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Next Generation Sequencing Revenue and Growth Rate (2013-2018)
8 South America Next Generation Sequencing Revenue by Countries
8.1 South America Next Generation Sequencing Revenue by Countries (2013-2018)
8.2 Brazil Next Generation Sequencing Revenue and Growth Rate (2013-2018)
8.3 Argentina Next Generation Sequencing Revenue and Growth Rate (2013-2018)
8.4 Colombia Next Generation Sequencing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Next Generation Sequencing by Countries
9.1 Middle East and Africa Next Generation Sequencing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Next Generation Sequencing Revenue and Growth Rate (2013-2018)
9.3 UAE Next Generation Sequencing Revenue and Growth Rate (2013-2018)
9.4 Egypt Next Generation Sequencing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Next Generation Sequencing Revenue and Growth Rate (2013-2018)
9.6 South Africa Next Generation Sequencing Revenue and Growth Rate (2013-2018)
10 Global Next Generation Sequencing Market Segment by Type
10.1 Global Next Generation Sequencing Revenue and Market Share by Type (2013-2018)
10.2 Global Next Generation Sequencing Market Forecast by Type (2018-2023)
10.3 Targeted Sequencing & Resequencing Revenue Growth Rate (2013-2023)
10.4 Whole Genome Sequencing Revenue Growth Rate (2013-2023)
10.5 Whole Exome Sequencing Revenue Growth Rate (2013-2023)
11 Global Next Generation Sequencing Market Segment by Application
11.1 Global Next Generation Sequencing Revenue Market Share by Application (2013-2018)
11.2 Next Generation Sequencing Market Forecast by Application (2018-2023)
11.3 Whole-genome Sequencing Revenue Growth (2013-2018)
11.4 Exome Sequencing Revenue Growth (2013-2018)
11.5 Targeted Resequencing Revenue Growth (2013-2018)
11.6 De Novo Sequencing Revenue Growth (2013-2018)
11.7 RNA Sequencing Revenue Growth (2013-2018)
11.8 ChIP Sequencing Revenue Growth (2013-2018)
11.9 Methyl Sequencing Revenue Growth (2013-2018)
11.10 Others Revenue Growth (2013-2018)
12 Global Next Generation Sequencing Market Size Forecast (2018-2023)
12.1 Global Next Generation Sequencing Market Size Forecast (2018-2023)
12.2 Global Next Generation Sequencing Market Forecast by Regions (2018-2023)
12.3 North America Next Generation Sequencing Revenue Market Forecast (2018-2023)
12.4 Europe Next Generation Sequencing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Next Generation Sequencing Revenue Market Forecast (2018-2023)
12.6 South America Next Generation Sequencing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Next Generation Sequencing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Next Generation Sequencing Picture
Table Product Specifications of Next Generation Sequencing
Table Global Next Generation Sequencing and Revenue (Million USD) Marke
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
